ZA202108150B - An inhalable fixed dose powder composition comprising glycopyrronium, formoterol and fluticasone propionate - Google Patents

An inhalable fixed dose powder composition comprising glycopyrronium, formoterol and fluticasone propionate

Info

Publication number
ZA202108150B
ZA202108150B ZA2021/08150A ZA202108150A ZA202108150B ZA 202108150 B ZA202108150 B ZA 202108150B ZA 2021/08150 A ZA2021/08150 A ZA 2021/08150A ZA 202108150 A ZA202108150 A ZA 202108150A ZA 202108150 B ZA202108150 B ZA 202108150B
Authority
ZA
South Africa
Prior art keywords
glycopyrronium
formoterol
powder composition
fixed dose
fluticasone propionate
Prior art date
Application number
ZA2021/08150A
Inventor
Sunil Chaudhari
Ganesh Jadhav
Girish Trivedi
Monika Tandon
Rahul Kodgule
Sushrut Kulkarni
Original Assignee
Glenmark Pharmaceutical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glenmark Pharmaceutical Ltd filed Critical Glenmark Pharmaceutical Ltd
Publication of ZA202108150B publication Critical patent/ZA202108150B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0001—Details of inhalators; Constructional features thereof
    • A61M15/0021—Mouthpieces therefor
    • A61M15/0023—Mouthpieces therefor retractable
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/001—Particle size control
    • A61M11/003—Particle size control by passing the aerosol trough sieves or filters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
    • A61M15/0033—Details of the piercing or cutting means
    • A61M15/0035—Piercing means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
    • A61M15/0033—Details of the piercing or cutting means
    • A61M15/0041—Details of the piercing or cutting means with movable piercing or cutting means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/06—Solids
    • A61M2202/064—Powder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2209/00—Ancillary equipment
    • A61M2209/06—Packaging for specific medical equipment

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA2021/08150A 2019-05-24 2021-10-22 An inhalable fixed dose powder composition comprising glycopyrronium, formoterol and fluticasone propionate ZA202108150B (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IN201921020572 2019-05-24
IN201921023615 2019-06-14
IN201921029676 2019-07-23
PCT/IB2020/054774 WO2020240350A1 (en) 2019-05-24 2020-05-20 An inhalable fixed dose powder composition comprising glycopyrronium, formoterol and fluticasone propionate

Publications (1)

Publication Number Publication Date
ZA202108150B true ZA202108150B (en) 2023-03-29

Family

ID=73552696

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2021/08150A ZA202108150B (en) 2019-05-24 2021-10-22 An inhalable fixed dose powder composition comprising glycopyrronium, formoterol and fluticasone propionate

Country Status (4)

Country Link
CO (1) CO2021017397A2 (en)
MX (1) MX2021014343A (en)
WO (1) WO2020240350A1 (en)
ZA (1) ZA202108150B (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9700135D0 (en) * 1997-01-20 1997-01-20 Astra Ab New formulation
ITMO20020297A1 (en) * 2002-10-16 2004-04-17 Roberto Oliva INHALER FOR SINGLE-DOSE PREPARATIONS IN CAPSULES.
KR20140012989A (en) * 2011-02-17 2014-02-04 시플라 리미티드 Combination of glycopyrrolate and a beta2 -agonist
WO2014007781A2 (en) * 2012-07-05 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Inhalation compositions
EA036153B1 (en) * 2012-07-05 2020-10-06 Арвен Айлак Санайи Ве Тиджарет А.С. Pharmaceutical composition for inhalation, packed dosage form, capsule, method of treating obstructive airway diseases and pharmaceutical kit
EP2821061B1 (en) * 2013-07-01 2017-12-20 Arven Ilac Sanayi Ve Ticaret A.S. Novel inhalation formulations

Also Published As

Publication number Publication date
WO2020240350A1 (en) 2020-12-03
CO2021017397A2 (en) 2022-01-17
MX2021014343A (en) 2022-01-06

Similar Documents

Publication Publication Date Title
ZA202110037B (en) Nicotine pouch composition and pouch comprising such
IL284835A (en) Pharmaceutical combination comprising tno155 and ribociclib
EP3297710A4 (en) Propellant based metered dose inhaler and food applicators and applicators
HK1245125A1 (en) Dry powder inhaler comprising fluticasone propionate and salmeterol xinafoat
EP3849404A4 (en) Small highly uniform nanomedicine compositions for therapeutic, imaging and theranostic applications
EP4023227A4 (en) Pharmaceutical composition and application thereof
IL272503A (en) Pharmaceutical composition comprising abiraterone acetate and darulotamide
IL285378A (en) Heterocyclic compound, pharmaceutical composition comprising same, preparation method therefor, and use thereof
IL286642A (en) Compositions, devices and methods for factor vii therapy
MX2018006799A (en) Pharmaceutical composition.
EP3927328A4 (en) Inhalable therapeutic agent
EP4223759A4 (en) Pyrazolopyridazinone compound, and pharmaceutical composition and use thereof
EP3347022A4 (en) Pharmaceutical composition including dutasteride and capsule formulation comprising the same
IL284099A (en) Adeno-associated viruses and their uses for inner ear therapy
ZA202104998B (en) Composition comprising tolfenpyrad and pyraclostrobin
ZA202108150B (en) An inhalable fixed dose powder composition comprising glycopyrronium, formoterol and fluticasone propionate
EP3861988A4 (en) Powder inhaler, method for assessing same, and use of same
LT3768241T (en) Topical composition comprising calcipotriol and betamethasone dipropionate
SG11202012005VA (en) Fluticasone furoate nasal preparation composition
EP4074304A4 (en) Fulvestrant pharmaceutical composition, preparation method therefor, and application thereof
IL284132A (en) Pharmaceutical compound, the method of its making and use as medicinal agent
IL285977A (en) Adeno-associated viruses and their uses for inner ear therapy
ZA202104261B (en) Combination pharmaceutical compositions and methods thereof
EP4071170A4 (en) Pharmaceutical composition, preparation method therefor and use thereof
EP3983050A4 (en) Medicament containment devices and associated compositions